European Pharmaceutical Review

JULY 13, 2023

3 With established drug development pathways, we are accustomed to a rigid structure of translation from bench to bedside. 5 These compounds have been shown in pre-clinical studies to have an array of potential effects on the immune, nervous, cardiovascular, respiratory and endocrine systems.

Compounding 98

Compounding Drug Development Clinical Pharmacology Documentation 98

pharmaphorum

OCTOBER 12, 2022

“We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says. In 2019, Del Bourgo and co-founder Julien Cottineau launched Whitelab Genomics and its AI platform dedicated to supporting the discovery and design of genomic therapies. “We

Drug Development 105

Drug Development Immunization Immunity Vaccines 105

PharmaShots

JANUARY 31, 2023

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Funding Value: $7M Founded Year: 2005 No. The company bagged its $6.3M IPO in Jun’22 offering shares at $4.25/unit. of Shares: 1.2M Funding Value: $7.7M

Vaccines 40

Vaccines Immunization Immunity Diabetes 40